Axio Biosolutions Revenue and Competitors
Estimated Revenue & Valuation
- Axio Biosolutions's estimated annual revenue is currently $17.7M per year.
- Axio Biosolutions's estimated revenue per employee is $96,875
- Axio Biosolutions's total funding is $21M.
Employee Data
- Axio Biosolutions has 183 Employees.
- Axio Biosolutions grew their employee count by -11% last year.
Axio Biosolutions's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Sales (India) | Reveal Email/Phone |
2 | Head Design | Reveal Email/Phone |
3 | Head – R&D | Reveal Email/Phone |
4 | Director – Finance | Reveal Email/Phone |
5 | Senior Manager – HR | Reveal Email/Phone |
6 | Area Business Manager | Reveal Email/Phone |
7 | Project Manager -R&D | Reveal Email/Phone |
8 | Co Founder | Reveal Email/Phone |
Axio Biosolutions Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12M | 155 | -4% | N/A | N/A |
#2 | $17.3M | 223 | 18% | N/A | N/A |
#3 | $11.1M | 143 | 34% | N/A | N/A |
#4 | $8.2M | 106 | 8% | N/A | N/A |
#5 | $9.5M | 123 | 10% | N/A | N/A |
#6 | $21.2M | 273 | 8% | N/A | N/A |
#7 | $12M | 155 | 8% | N/A | N/A |
#8 | $18.9M | 244 | 5% | N/A | N/A |
#9 | $12.5M | 161 | 9% | N/A | N/A |
#10 | $20.5M | 264 | 8% | N/A | N/A |
What Is Axio Biosolutions?
Axio is a deep science medtech company focused on Advanced Surgical, Trauma and woundcare. Makers of India's first USFDA cleared hemostat - AXIOSTAT (a patented, Fda 510k and CE approved medical device made from 100% Chitosan) and MaxioCel (a chitosan microfiber dressing for Diabetic foot ulcers and other chronic ulcers) Axio develops and commercializes active medical products using novel biomaterials for advanced woundcare. We believe in creating value by delivering affordable solutions for unmet health care needs.
keywords:Healthcare, Medical Devices, Defense, Hospitals$21M
Total Funding
183
Number of Employees
$17.7M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Axio Biosolutions News
... Verpackungsmaschinen GmbH, Sanara MedTech Inc., Reapplix A/S, Cardinal Health, Ostomed, Kerecis, Axio Biosolutions Pvt Ltd, NanoVibronix.
Axio Biosolutions, a Boston and Bengaluru-based medical device company has raised $6 Mn in Series B2 led by TrueScale Capital. Existing investors Omidyar Network India, University of California – Ratan Tata Fund, and Accel also participated in this funding round. With this deal, Sameer Nath, man ...
In total, Axio has raised over $20 million till date Med-tech company Axio Biosolutions has raised $6 million in a Series B2 equity raise led by TrueScale Capital. Existing investors such as Omidyar Network India, University of California–Ratan Tata Fund, and Accel also participated in the roun ...
ETtechIllustration: Rahul Awasthi Medical technology company Axio Biosolutions on Tuesday said it has raised $6 million (about Rs 45 crore) in a funding round led by Truescale Capital. Existing investors Omidyar Network India, University of California-Ratan Tata Fund, and Accel also participate ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $12.1M | 183 | 5% | N/A |
#2 | $33.2M | 183 | 3% | N/A |
#3 | N/A | 184 | 6% | N/A |
#4 | $16.4M | 186 | 50% | N/A |
#5 | $14.8M | 186 | 17% | N/A |